![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Treatment-Naïve Black Patients Treated with Boceprevir (BOC) Combined with Peginterferon alfa-2b + Ribavirin (PR): Results from HCV SPRINT-2
|
|
|
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
Jonathan McCone Jr. MD1; Ira M. Jacobson MD2; Bruce R. Bacon MD3; Lisa D. Pedicone PhD4; Venkata S. Goteti PhD4; Margaret Burroughs MD4; Clifford A. Brass MD, PhD4; Janice K. Albrecht PhD4; K. Rajender Reddy MD5
1Gastroenterology-Hepatology-Certified Endoscopy Centers, Alexandria, VA; 2Weill Cornell Medical College, New York, NY; 3St. Louis University School of Medicine, St. Louis, MO; 4Merck Sharp & Dohme Corp., Whitehouse Station, NJ; 5University of Pennsylvania, Philadelphia, PA
![AASLD1.gif](../images/111611/111611-1/AASLD1.gif)
![AASLD2.gif](../images/111611/111611-1/AASLD2.gif)
![AASLD3.gif](../images/111611/111611-1/AASLD3.gif)
![AASLD4.gif](../images/111611/111611-1/AASLD4.gif)
![AASLD5.gif](../images/111611/111611-1/AASLD5.gif)
![AASLD6.gif](../images/111611/111611-1/AASLD6.gif)
![AASLD7.gif](../images/111611/111611-1/AASLD7.gif)
![AASLD8.gif](../images/111611/111611-1/AASLD8.gif)
![AASLD9.gif](../images/111611/111611-1/AASLD9.gif)
![AASLD10.gif](../images/111611/111611-1/AASLD10.gif)
![AASLD11.gif](../images/111611/111611-1/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|